Belimumab/rituximabSepsis and miliary tuberculosis reactivation: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2046卷 / 1期

关键词：

D O I：

10.1007/s40278-025-77461-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：73 / 73

相关论文

共 50 条

[1] RituximabSepsis and acute hepatitis B reactivation: 2 case reports
Reactions Weekly, 2020, 1811 (1) : 240 - 240
[2] Adalimumab/infliximabActive tuberculosis and miliary tuberculosis: 2 case reports
Reactions Weekly, 2016, 1624 (1) : 17 - 17
[3] CRYPTIC MILIARY TUBERCULOSIS - 2 CASE-REPORTS
BENIT, C
PICARD, M
BRION, N
ROBIN, PM
DELAVIERRE, P
FRIOCOURT, P
PICARD, R
SEMAINE DES HOPITAUX, 1982, 58 (22): : 1383 - 1387
[4] AdalimumabReactivation of pulmonary tuberculosis and disseminated miliary tuberculosis: 2 case reports
Reactions Weekly, 2018, 1693 (1) : 18 - 18
[5] InfliximabLatent tuberculosis reactivation and neurofibromatosis: 2 case reports
Reactions Weekly, 2016, 1604 (1) : 92 - 92
[6] Immune globulin/plasma/rituximabSepsis: 2 case reports
Reactions Weekly, 2018, 1727 (1) : 157 - 157
[7] LenalidomideAcquired drug resistance, reactivation of Mycobacterium tuberculosis and miliary tuberculosis: case report
Reactions Weekly, 2019, 1755 (1) : 195 - 195
[8] InfliximabPulmonary tuberculosis reactivation and cryptococcal meningitis: 2 case reports
Reactions Weekly, 2018, 1684 (1) : 133 - 133
[9] RituximabUrinary tract infection and reactivation of tuberculosis: 2 case reports
Reactions Weekly, 2019, 1740 (1) : 290 - 290
[10] AdalimumabMycobacterium tuberculosis leading to miliary tuberculosis and congenital tuberculosis (in-utero exposure): 2 case reports
Reactions Weekly, 2017, 1670 (1) : 14 - 14

← 1 2 3 4 5 →